60-Patient National Phase I-b Clinical Trial to Begin in 2012 Jersey City, NJ — February 20, 2012 — S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug…
Read more ›